Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

515 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer.
Shatsky RA, Batra-Sharma H, Helsten T, Schwab RB, Pittman EI, Pu M, Weihe E, Ghia EM, Rassenti LZ, Molinolo A, Cabrera B, Breitmeyer JB, Widhopf Ii GF, Messer K, Jamieson C, Kipps TJ, Parker BA. Shatsky RA, et al. Among authors: jamieson c. Breast Cancer Res. 2024 Mar 13;26(1):46. doi: 10.1186/s13058-024-01805-w. Breast Cancer Res. 2024. PMID: 38481291 Free PMC article. No abstract available.
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer.
Shatsky RA, Batra-Sharma H, Helsten T, Schwab RB, Pittman EI, Pu M, Weihe E, Ghia EM, Rassenti LZ, Molinolo A, Cabrera B, Breitmeyer JB, Widhopf GF 2nd, Messer K, Jamieson C, Kipps TJ, Parker BA. Shatsky RA, et al. Among authors: jamieson c. Breast Cancer Res. 2024 Feb 26;26(1):32. doi: 10.1186/s13058-024-01782-0. Breast Cancer Res. 2024. PMID: 38408999 Free PMC article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 39112241
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells.
Botta GP, Chao J, Ma H, Hahn M, Sierra G, Jia J, Hendrix AY, Nolte Fong JV, Ween A, Vu P, Miller A, Choi M, Heyman B, Daniels GA, Kaufman D, Jamieson C, Li Z, Cohen E. Botta GP, et al. Among authors: jamieson c. J Immunother Cancer. 2024 Feb 5;12(2):e007927. doi: 10.1136/jitc-2023-007927. J Immunother Cancer. 2024. PMID: 38316518 Free PMC article.
Getting to the core of ADAR2 activity in AML.
Steel K, Jamieson C. Steel K, et al. Among authors: jamieson c. Blood. 2023 Jun 22;141(25):3014-3015. doi: 10.1182/blood.2023019923. Blood. 2023. PMID: 37347500 Free article. No abstract available.
Malignant A-to-I RNA editing by ADAR1 drives T-cell acute lymphoblastic leukemia relapse via attenuating dsRNA sensing.
Rivera M, Zhang H, Pham J, Isquith J, Zhou QJ, Sasik R, Mark A, Ma W, Holm F, Fisch KM, Kuo DJ, Jamieson C, Jiang Q. Rivera M, et al. Among authors: jamieson c. Res Sq [Preprint]. 2023 Jun 16:rs.3.rs-2444524. doi: 10.21203/rs.3.rs-2444524/v2. Res Sq. 2023. Update in: Cell Rep. 2024 Feb 27;43(2):113704. doi: 10.1016/j.celrep.2024.113704 PMID: 37398458 Free PMC article. Updated. Preprint.
Stem-Cell Aging and Pathways to Precancer Evolution.
Jamieson CHM, Weissman IL. Jamieson CHM, et al. N Engl J Med. 2023 Oct 5;389(14):1310-1319. doi: 10.1056/NEJMra2304431. N Engl J Med. 2023. PMID: 37792614 Review. No abstract available.
Stereochemical Control of Splice Modulation in FD-895 Analogues.
Chan WC, Trieger KA, La Clair JJ, Jamieson CHM, Burkart MD. Chan WC, et al. Among authors: jamieson chm. J Med Chem. 2023 May 25;66(10):6577-6590. doi: 10.1021/acs.jmedchem.2c01893. Epub 2023 May 8. J Med Chem. 2023. PMID: 37155693 Free PMC article.
515 results